Liquid Biopsies for Dynamic Monitoring of EGFR Mutations in Lung Cancer

被引：1
|
作者：
Schuler, Martin [1 ]
机构：
[1] Univ Hosp Essen, West German Canc Ctr, Essen, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
EGFR; biomarker; Genomics; Resistance;
D O I：
10.1016/j.jtho.2016.11.075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SC04.04
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [41] The next tier of EGFR resistance mutations in lung cancer
    Hannah L. Tumbrink
    Alena Heimsoeth
    Martin L. Sos
    Oncogene, 2021, 40 : 1 - 11
  • [42] PULMONARY THROMBOEMBOLISM IN LUNG CANCER PATIENTS AND EGFR MUTATIONS
    Yamazaki, Susumu
    Okano, Tetsuya
    Ishikawa, Rinako
    Kobayashi, Kunihiko
    RESPIROLOGY, 2013, 18 : 22 - 22
  • [43] The next tier of EGFR resistance mutations in lung cancer
    Tumbrink, Hannah L.
    Heimsoeth, Alena
    Sos, Martin L.
    ONCOGENE, 2021, 40 (01) : 1 - 11
  • [44] THE RELATIONSHIP BETWEEN EGFR MUTATIONS AND THE CLINICOPATHOLOGIC FEATURES OF LUNG ADENOCARCINOMAS DIAGNOSED BY THE SMALL BIOPSIES
    Shin, Kyeong-Cheol
    Chung, Jin Hong
    Lee, Kwan Ho
    Kim, Mi Jin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S661 - S662
  • [45] Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
    R. B. Verheijen
    T. T. van Duijl
    M. M. van den Heuvel
    D. Vessies
    M. Muller
    J. H. Beijnen
    J. M. Janssen
    J. H. M. Schellens
    N. Steeghs
    D. van den Broek
    A. D. R. Huitema
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 269 - 276
  • [46] Liquid Biopsies in Patients with EGFR Mutated Non-Small Cell Lung Cancer Undergoing Curative Treatment
    Hansen, Eva B.
    Sorensen, Boe S.
    Meldgaard, Peter
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S607 - S607
  • [47] Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors
    Haber, D. A.
    Bell, D. W.
    Sordella, R.
    Kwak, E. L.
    Godin-Heymann, N.
    Sharma, S. V.
    Lynch, T. J.
    Settleman, J.
    Molecular Approaches to Controlling Cancer, 2005, 70 : 419 - 426
  • [48] Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
    Verheijen, R. B.
    van Duijl, T. T.
    van den Heuvel, M. M.
    Vessies, D.
    Muller, M.
    Beijnen, J. H.
    Janssen, J. M.
    Schellens, J. H. M.
    Steeghs, N.
    van den Broek, D.
    Huitema, A. D. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (02) : 269 - 276
  • [49] Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance
    Ni, Jianjiao
    Weng, Linqian
    Liu, Yi
    Sun, Zhao
    Bai, Chunmei
    Wang, Yingyi
    ONCOLOGY LETTERS, 2017, 13 (06) : 4549 - 4557
  • [50] Resistance to EGFR blockade in colorectal cancer: liquid biopsies and latent subclones
    Konieczkowski, David J.
    Garraway, Levi A.
    CELL RESEARCH, 2013, 23 (01) : 13 - 14
12345